Khazanah Nasional Berhad has recently submitted its 13F-HR report, detailing its investment holdings as of December 31, 2025. This filing is crucial as it provides insight into the company's strategic asset allocation and investment decisions.

The report shows that Khazanah has a total of 124 positions, with a reported total value of approximately $1.66 billion. This diverse portfolio includes significant stakes in well-known companies across various sectors, highlighting Khazanah's broad investment approach.

Khazanah Nasional Berhad, based in Kuala Lumpur, Malaysia, operates as a sovereign wealth fund. It is tasked with managing the commercial assets of the Government of Malaysia, focusing on long-term value creation and sustainable economic growth. The company does not have a specific SIC code or ticker symbol, as it operates primarily in the investment sector.

The filing, dated October 20, 2026, includes a signature from Mohamad Hishammudin bin Hamdan, the Chief Investment Officer, indicating the report's authenticity and compliance with SEC regulations. The report also notes that there are no other included managers, suggesting that Khazanah manages its investments independently.

Among the notable holdings listed in the filing are major corporations such as Abbott Labs, AbbVie Inc, and Alphabet Inc, among others. These investments reflect Khazanah's strategy to diversify its portfolio across various industries, including healthcare, technology, and consumer goods.

This filing may impact how other investment firms evaluate their strategies in the current market environment. As Khazanah continues to adapt its investment approach, competitors may look to adjust their own portfolios in response to the insights provided by this report.

Looking ahead, the filing does not specify any upcoming actions or changes to Khazanah's investment strategy. However, the company is expected to continue monitoring its investments closely and may file additional reports as required by regulatory standards.

For more details, the filing can be accessed through the SEC's website under accession number 0000905148-26-004518.